Stocks making the biggest moves in the premarket: Prevail Therapeutics, Moderna, Apple, Pinterest & more

Stocks making the biggest moves in the premarket: Prevail Therapeutics, Moderna, Apple, Pinterest & more

Take a look at some of the biggest movers in the premarket:Eli Lilly (LLY) – The drugmaker announced a deal to buy Prevail Therapeutics (PRVL) for $880 million or $22.50 per share, with Prevail shareholders also receiving a "contingent value right" worth up to $4 per share subject to future regulatory approvals of Prevail drugs. Separately, Eli Lilly increased its quarterly dividend to 85 cents per share from 74 cents, a 15% increase. Lilly also raised its full-year earnings forecast. Prevail jumped 86% in premarket trading as of 7:38 a.m. ET. Eli Lilly shares gained 2%.Bristol-Myers (BMY) – Goldman Sachs added the drugmaker's stock to its "Conviction List," on expectations of a number of Food and Drug Administration approvals as well as pipeline data that should drive up earnings estimates. Bristol shares added 2% in premarket trading as of 7:38 a.m. ET.WPP (WPP) – WPP will restate its financial results from 2017 to 2019, but the world's biggest advertising firm said headline operating profit and cash flow would not be impacted. WPP said its method of presenting certain cash measures and hedges did not meet normal accounting standards for those years.Baidu (BIDU) – Baidu is considering making its own electric